Endpoints News· @endpts · X·· 3 小时前AI 评分42
AI 导读
Verastem度过了一个忙碌的早晨：胰腺癌领域的新KRAS数据、2.5亿美元融资，以及CEO的离职。https://endpoints.news/verastem-makes-its-stand-as-a-revmed-competitor-in-pancreatic-cancer/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
Verastem had a busy morning: new KRAS data in pancreatic cancer, a $250M raise and its CEO’s departure. https://endpoints.news/verastem-makes-its-stand-as-a-revmed-competitor-in-pancreatic-cancer/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源：Endpoints News · x.com